Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort

Bibliographic Details
Main Authors:	Leonard, H, Revis, J, Matthews, L, Kitley, J, Leite, M, Palace, J
Format:	Conference item
Published:	2012

Similar Items

Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
by: Nour, M, et al.
Published: (2014)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
by: George, J, et al.
Published: (2012)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
by: Matthews, L, et al.
Published: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
by: Matthews, L, et al.
Published: (2013)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
by: Kim, W, et al.
Published: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
by: Nour, M, et al.
Published: (2014)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
by: Kitley, J, et al.
Published: (2014)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
by: Kitley, J, et al.
Published: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
by: Kitley, J, et al.
Published: (2013)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
by: Nour, M, et al.
Published: (2015)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
by: Kitley, J, et al.
Published: (2013)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
by: Leite, M, et al.
Published: (2009)

The evolving clinical spectrum of neuromyelitis optica
by: Viegas, S, et al.
Published: (2008)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
by: Kitley, J, et al.
Published: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
by: Kitley, J, et al.
Published: (2014)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
by: Kitley, J, et al.
Published: (2012)

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE
by: Kitley, J, et al.
Published: (2012)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
by: Cheng, F, et al.
Published: (2014)

A clinical/immunological neuromyelitis optica association study
by: Kitley, J, et al.
Published: (2014)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
by: Matthews, L, et al.
Published: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
by: Luppe, S, et al.
Published: (2012)

Seasonal pattern of variation in neuromyelitis optica relapses
by: Elsone, L, et al.
Published: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
by: Kitley, J, et al.
Published: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
by: Kitley, J, et al.
Published: (2014)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
by: Kitley, J, et al.
Published: (2012)

Racial differences in neuromyelitis optica spectrum disorder
by: Kim, S, et al.
Published: (2018)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
by: Kitley, J, et al.
Published: (2013)

Pain in patients with neuromyelitis optica spectrum disorders
by: E. S. Novikova, et al.
Published: (2024-08-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)

A practical guide to the treatment of neuromyelitis optica.
by: Palace, J, et al.
Published: (2012)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
by: Jacob, A, et al.
Published: (2012)

Differential diagnosis of neuromyelitis optica spectrum disorders
by: Sung-Min Kim, et al.
Published: (2017-07-01)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
by: Kitley, J, et al.
Published: (2011)

DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK
by: Kitley, J, et al.
Published: (2012)